Sandy Wong
@SandyWong02111
Followers
1K
Following
9K
Media
55
Statuses
4K
RT @MM_Hub: CONGRESS | #ASH24 | POSTER . Caitlin Costello @Ccostello7, UCSD Moores Cancer Center, shares results from the optimized lymphod….
0
4
0
RT @rajshekharucms: In AL #Amyloidosis, we are no longer in an era of ~30% early mortality! .New data by @Slade_Mellgard shows 6 mo early m….
0
11
0
RT @Bethfaiman: #BCL2 inhibitors in #myeloma and #Amyloidosis? Yes please! Lisaftoclax in #RRMM @khouri_jack @CleClinicMD #ASH24
https://t….
0
3
0
RT @RahulBanerjeeMD: #ASH24 MajesTEC-4! Zamagni et al: Safety run-in for tec + len maintenance after ASCT. First time we're seeing bsAb ma….
0
12
0
RT @RahulBanerjeeMD: #ASH24 excellent work by my @fredhutch colleague @DimaDanai on behalf of the US #MMsm consortium 👏. Prior BCMA therap….
0
10
0
RT @HadidiSamer: #ASH24 #mmsm @ASH_hematology . Oral myeloma: MagnetisMM-20. Carf+Elra.low no. of pts .Responses are high (ORR 100%). 1 dea….
0
6
0
RT @RahulBanerjeeMD: #ASH24 Excellent work by @hcheruvalath @MeeraMohanMD et al showing value of IVIG with BCMA-targeted bsAbs in #MMsm. 🤯….
0
8
0
RT @HadidiSamer: #ASH24 #mmsm @ASH_hematology . Oral amyloidosis: Final update of ANDROMEDA. A great study with OS improvement (despite mor….
0
5
0
RT @bdermanmd: Even in the best case scenario (>9 months), still leaves something to be desired. Is switching target after BCMA CAR T a bet….
0
5
0
RT @HadidiSamer: #ASH24 #mmsm @ASH_hematology . Oral myeloma: Anti-BCMA/GPRC5D Bispecific CAR T-Cells in Patients with Refractory and Relap….
0
2
0
RT @bdermanmd: Tec-Len safety run in as post-ASCT maintenance #ASH24 #mmsm #mmMRD .- Convenient dosing schedule.- Nearly everyone got signi….
0
5
0
RT @bdermanmd: More on teclistamab. this time with pomalidomide and daratumumab. Here we see a signal for very high infection rates, incl….
0
13
0
RT @bdermanmd: Subgroup analysis of AURIGA: Dara-Len vs Len for pts with MRD+ post-ASCT. I like the breakdown re: benefit in high-risk dise….
0
8
0
RT @HadidiSamer: #ASH24 #mmsm @ASH_hematology . Oral: amyloidosis. MRD -ve in AL amyloidosis is associated with better outcomes, no correla….
0
2
0
RT @RahulBanerjeeMD: #ASH24 and the best for last! Our fearless US #MMsm consortium leader #DorisHansen presenting the most sophisticated a….
0
12
0
RT @bdermanmd: AQUILA: Daratumumab x 3 years vs. active surveillance for smoldering myeloma.- All patients had advanced imaging (CT/PET/MRI….
0
13
0